Pharmafit Provence

Professional product catalogue

Anticoagulants

Anticoagulants comprise several medicine families acting on blood coagulation. Vitamin K antagonists, heparins and direct coagulation-factor inhibitors do not share one mechanism or one presentation. This professional category explains their differences, from oral forms to injectable preparations. It also preserves an essential distinction from antiplatelet medicines: belonging to the antithrombotic field does not mean acting at the same stage of blood function. Understanding that vocabulary supports precise pharmaceutical interpretation without providing an individual anticoagulation plan or conversion between products.

Products in this category

153 products

Understanding anticoagulants

Coagulation and pharmacological targets

Coagulation involves a sequence of reactions leading to fibrin formation. Anticoagulants influence this cascade in different ways. Vitamin K antagonists affect production of certain factors dependent on that vitamin; direct inhibitors target, among other factors, thrombin or factor Xa. Heparins form another family. These terms identify mechanisms and explain why anticoagulant alone cannot describe a substance, administration route or monitoring framework. A shared broad purpose therefore does not establish the same pharmaceutical identity or clinical context for different medicines placed in this category.

Oral and injectable presentations

Tablets and capsules differ from injectable solutions, prefilled syringes and other parenteral preparations. Quantities may be expressed as mass or units of activity, depending on the product. That distinction remains part of identification alongside concentration and container volume. A similarly sized syringe does not establish an identical quantity of medicine. Pharmacological family, format and quantity unit together provide more precise reference points than the appearance of the outer pack, particularly where products within related families use different ways of expressing activity.

Pharmacy interpretation and monitoring

Prevention and treatment of thromboembolic events are documented contexts that do not automatically transfer between medicines. Monitoring also differs according to family and clinical situation. INR is particularly associated with vitamin K antagonist monitoring rather than being a universal reference for every anticoagulant. In pharmacy practice, interpreting the complete prescription and medicinal presentation distinguishes these frameworks while retaining attention to medicine combinations and relevant safety information. The category consequently explains the field without setting laboratory targets, recommending a regimen or establishing a replacement between oral and injectable products.

Frequently asked questions

Are anticoagulant and antiplatelet synonyms?

No. They concern different mechanisms of haemostasis. This category preserves anticoagulant families rather than including every antithrombotic medicine.

Does INR describe monitoring of every anticoagulant?

No. It is particularly used with vitamin K antagonists. Other families have different monitoring frameworks depending on the medicine and clinical situation.